Product Images Gabapentin

Gabapentin is a medication that is available in the form of tablets of 800 mg each in a bottle of 30 tablets. The medication should be kept out of the reach of children and should be stored at 20-25°C. The medication should be used in accordance with the package insert. The medicine was repackaged by RemedyRepack Inc. and was manufactured by ACI Healthcare USA, Inc. in Coral Springs, FL. The expiration date and lot number for this medicine are not available.*

Gabapentin is a medication that comes in a tablet form with a dose of 800 mg. The package contains 90 tablets and is manufactured by ACI Healthcare USA, Inc located in Coral Springs, FL. It is a prescription medicine and the prescription number and expiration date is not available. The medicine is stored between 20-25°C (58-77°F) but can be stored between 15-30°C (59-86°F) according to USP. Directions for use can be found on the package insert. The medication is repackaged by RemedyRepack Inc. located in Indiana, PA.*

Gabapentin is a drug that comes in the form of 800 mg tablets with a quantity of 180. It is only available through a prescription with the RX ONLY label. The drug is manufactured by ACI Healthcare USA, Inc. which is based in Coral Springs, FL with a source NDC number of 71093-0112-05. The expiration date and LOT# are not available in the text. The repackaging is done by RemedyRepack Inc. located in Indiana, PA, with contact information provided. The drug should be kept out of reach of children and stored between 20-25°C or 58-77°F with excursions permitted to 15-30°C (59-86°F) - as per USP guidelines. The package insert should be consulted for directions.*

This is a formula used for estimating creatinine clearance in patients based on their age, weight, and serum creatinine levels. The formula involves multiplying the patient's age (in years) by their weight (in kg), and then dividing by a factor of 72 multiplied by their serum creatinine level (in mg/dL). For female patients, the result is further multiplied by a factor of 0.85.*

This is a table showing the mean pain score for a 4-week fixed dose period. It includes two treatment options: Gabapentin 1800 mg/day and Gabapentin 2400 mg/day, as well as a placebo control group. There are no other details or explanations available.*

The text describes the proportion of responders or patients with more than 50% reduction in pain score in controlled PHN studies. It also includes information on the statistical significance of the findings. The figure shows the results of the two studies conducted. However, the text appears to be incomplete and missing crucial information.*